Article info
PDFShort report
Somatic NKX2-5 mutations as a novel mechanism of disease in complex congenital heart disease
- Correspondence to: J Borlak Drug Research and Medical Biotechnology, Fraunhofer Institute of Toxicology and Experimental Medicine, Nikolai-Fuchs-Strasse 1, D-30625 Hanover, Germany; borlakitem.fraunhofer.de
Citation
Somatic NKX2-5 mutations as a novel mechanism of disease in complex congenital heart disease
Publication history
- Received April 9, 2004
- Accepted April 13, 2004
- First published September 1, 2004.
Online issue publication
September 01, 2004
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Copyright 2004 Journal of Medical Genetics